New cancer clinical trial: Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

Published on: June 25, 2018 at 12:00PM
Condition:   HER2 Negative Breast Cancer
Intervention:   Other: Response monitoring (no intervention)
Sponsor:   New Mexico Cancer Care Alliance
Recruiting
https://ift.tt/2tDr65P